NasdaqCM - Delayed Quote USD

Cocrystal Pharma, Inc. (COCP)

1.4600
-0.0850
(-5.50%)
At close: May 14 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
17,878
17,878
21,159
18,137
14,221
Operating Income
-17,878
-17,878
-21,159
-18,137
-14,221
Net Non Operating Interest Income Expense
537
537
640
-2
-4
Other Income Expense
-163
-163
2,535
-20,698
40
Pretax Income
-17,504
-17,504
-17,984
-38,837
-14,185
Net Income Common Stockholders
-17,504
-17,504
-17,984
-38,837
-14,185
Diluted NI Available to Com Stockholders
-17,504
-17,504
-17,984
-38,837
-14,185
Basic EPS
-1.72
-1.72
-1.87
-4.77
-0.16
Diluted EPS
-1.72
-1.72
-1.87
-4.77
-0.16
Basic Average Shares
10,174
10,174
9,651
8,143
7,364
Diluted Average Shares
10,174
10,174
9,651
8,143
7,364
Total Operating Income as Reported
-17,878
-17,878
-18,559
-38,829
-14,221
Total Expenses
17,878
17,878
21,159
18,137
14,221
Net Income from Continuing & Discontinued Operation
-17,504
-17,504
-17,984
-38,837
-14,185
Normalized Income
-17,341
-17,341
-20,519
-18,139
-14,225
Interest Expense
--
--
--
2
4
Net Interest Income
537
537
640
-2
-4
EBIT
-17,878
-17,878
-21,159
-18,137
-14,181
EBITDA
-17,432
-17,432
-21,159
-17,749
-13,799
Reconciled Depreciation
446
446
-1,388
388
382
Net Income from Continuing Operation Net Minority Interest
-17,504
-17,504
-17,984
-38,837
-14,185
Total Unusual Items Excluding Goodwill
-163
-163
2,535
-20,698
40
Total Unusual Items
-163
-163
2,535
-20,698
40
Normalized EBITDA
-17,269
-17,269
-23,694
2,949
-13,839
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/22/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XBIO Xenetic Biosciences, Inc.
3.1200
0.00%
 
OSRH OSR Holdings, Inc.
1.1700
-3.70%
 
4DN.F Denali Therapeutics Inc.
12.37
-2.41%
 
MDXXF Pharmala Biotech Holdings Inc.
0.0850
0.00%
 
NMLSF Restart Life Sciences Corp.
0.0570
0.00%
 
VTVT vTv Therapeutics Inc.
21.31
+2.45%
 
EQ Equillium, Inc.
0.3733
-2.30%
 
EVLO Evelo Biosciences, Inc.
0.0003
0.00%
 
SCPX Scorpius Holdings, Inc.
0.0488
-7.05%
 
ROIV Roivant Sciences Ltd.
10.67
-0.84%